Trial Profile
An open label study of humira (adalimumab)in the treatment of patients with severe psoriasis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Aug 2017
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Psoriasis
- Focus Therapeutic Use
- 31 Jul 2017 Status changed from recruiting to completed.
- 14 Jul 2014 New trial record